Found 20 matching trials
Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes
PHASE3The purpose of this study is to determine if albiglutide is safe and effect...
Location
GSK Investigational Site
Safety and Efficacy of Albiglutide in Type 2 Diabetes
PHASE3The purpose of this study is to determine the safety, tolerability and effi...
Location
GSK Investigational Site
In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
PHASE2This study is a placebo-controlled study in patients with Type 2 Diabetes M...
Location
GSK Investigational Site
Albiglutide Thorough ECG Study in Healthy Volunteers
PHASE1This study is designed to investigate the effect of treatment with albiglut...
Location
Multiple Locations
Dose Ranging Study of Albiglutide in Japanese Subjects
PHASE2This is a randomized, double-blind, placebo-controlled, multicenter, 4-para...
Location
GSK Investigational Site
A Study to Evaluate Pharmacokinetics, Safety and Efficacy of Albiglutide in Pediatric Subjects With Type 2 Diabetes Mellitus
PHASE3The incidence of Type 2 Diabetes Mellitus (T2DM) is increasing day by day b...
Location
GSK Investigational Site
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
PHASE3This study is designed to examine the efficacy and safety of 2 dose levels ...
Location
GSK Investigational Site
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
PHASE3This randomized, double-blind, active-controlled study evaluates the effica...
Location
GSK Investigational Site
A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
PHASE4The drug effects will be studied after a single dose of 50 milligram (mg) a...
Location
GSK Investigational Site
Albiglutide Glucose Clamp Study in Subjects With Type 2 Diabetes
PHASE2This is a stepped glucose clamp study designed to investigate the effect of...
Location
GSK Investigational Site